Skip to main content
Premium Trial:

Request an Annual Quote

BCW Index Rises as Four Firms Reach 52-Week Highs

BCW Index Rises as Four Firms Reach 52-Week Highs

The BioCommerce Week Index posted a healthy 2.56 percent gain for the five-day trading period ended Tuesday, as four components of the 15-company Index hit 52-week highs. Agilent, Bio-Rad, Qiagen, and Sigma-Aldrich all touched yearly highs during the tracking period. Agilent has been hovering within a couple of dollars of its 52-week high for the past few weeks.

Qiagen's shares climbed steadily throughout July and hit its high of $13.83 on Tuesday, a day after it announced the acquisition of protein sample prep technologies (see related article), before closing at $13.48. Bio-Rad also has had a steady climb since early May, when it reported a 14-percent increase in revenue for its first quarter. Investors appeared to be unfazed by the news last week that rival Invitrogen would acquire BioSource International — a Bio-Rad acquisition target. Sigma-Aldrich hit its 52-week high on a strong second-quarter financial report, which boasted a 27.4 percent growth in revenue.

Though it didn't hit a 52-week high, Stratagene came close, as its shares climbed 22 percent during the five-day tracking period. The unusually robust gain was due to a brief article published in the most recent issue of BusinessWeek spotlighting the firm's growth potential.

In comparison, the Dow Jones gained a miniscule .1 percent for the week, while the Nasdaq gained 1.9 percent, and the Nasdaq Biotech Index rose 2.1 percent.

BioCommerce Week’s Index to the
Diversified Molecular Biology Tools Companies
Company
Ticker
Current Price
(
August 2, 2005)
Last Price
(
July 26, 2005)
% Change
Agilent
A
26.63
25.98
2.50
Applied Biosystems
ABI
21.08
19.77
6.63
Beckman
BEC
54
53.55
0.84
Bio-Rad
BIO
62.52
59.2
5.61
Bruker
BRKR
4.23
4.08
3.68
GE
GE
34.25
34.7
-1.30
Harvard Bio
HBIO
3.42
3.26
4.91
Invitrogen
IVGN
86.14
86.5
-0.42
Molecular Devices
MDCC
21.06
21.77
-3.26
PerkinElmer
PKI
20.75
21.55
-3.71
Qiagen
QGEN
13.48
13.08
3.06
Sigma
SIAL
63.81
57.69
10.61
Strategene
STGN
10
8.2
21.95
Thermo
TMO
29.49
29.7
-0.71
Waters
WAT
45.07
44.5
1.28
Index Average
33.06
32.24
2.56
The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.